{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-054459","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2026-08-06T21:07:12+00:00","discovered_at":"2026-08-06T21:08:21.405045+00:00","generated_at":"2026-08-06T21:08:27.134034+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sanuwave Q2 revenue $9.7M (-3% YoY), net loss $0.7M; withdraws FY2026 guidance on CMS reimbursement uncertainty","bullets":["Revenue $9.7M, down 3% from $10.1M in Q2 2025; gross margin 76.2% vs 78.1%.","GAAP operating loss $(0.3)M vs income $1.4M; net loss $0.7M vs net income $0.6M.","Adjusted EBITDA $1.2M, down from $3.2M; Ultramist system sales fell to 82 units from 116.","Ultramist applicator revenue rose 13% to $7.3M, driven by 27% YoY unit volume growth.","Withdraws FY2026 guidance due to CMS proposed 2027 97610 reimbursement rule; will reassess after final rule."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-054459","json":"https://secwatch.observer/filing/0001628280-26-054459.json","markdown":"https://secwatch.observer/filing/0001628280-26-054459.md","text":"https://secwatch.observer/filing/0001628280-26-054459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/0001628280-26-054459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/snwv-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T21:08:27.134034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}